- $123.72m
- -$192.51m
- $16.66m
- 49
- 35
- 34
- 34
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.116 | 0.656 | 6.62 | 15.5 | 16.7 |
Cost of Revenue | |||||
Gross Profit | — | — | 3.41 | 7.09 | 8.51 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 17 | 34.3 | 78.1 | 113 | 120 |
Operating Profit | -16.9 | -33.6 | -71.5 | -97.2 | -103 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -16 | -32.8 | -71.2 | -93 | -86.3 |
Net Income After Taxes | -16 | -32.8 | -71.2 | -93 | -86.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -16 | -32.8 | -71.2 | -93 | -86.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -16 | -32.8 | -71.2 | -93 | -86.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.18 | -0.553 | -1.17 | -1.49 | -1.35 |
Dividends per Share |